查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1949848

2026年全球双磷酸盐市场报告

Bisphosphonates Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，双磷酸盐市场显着扩张，从2025年的57亿美元成长到2026年的60.3亿美元，复合年增长率为5.8%。过去几年的成长可归因于人口老化加剧、停经后骨质疏鬆症的盛行率上升、医生主导的骨骼密度筛检、医院进行的骨质疏鬆症管理以及注射用双磷酸盐的普及应用。

预计未来几年双磷酸盐市场将稳定成长，到2030年市场规模将达到74.5亿美元，复合年增长率（CAGR）为5.4%。预测期内的成长要素包括老年人口的成长、居家骨质疏鬆症照护的普及、对长效製剂的偏好、骨骼健康意识的提高以及学名药的广泛应用。预测期内的主要趋势包括骨质疏鬆症治疗需求的不断增长、长效注射疗法的日益普及、非专利双磷酸盐的广泛应用、对骨折预防的日益重视以及综合骨骼健康疗法的推出。

预计未来骨质疏鬆症盛行率的上升将推动双磷酸盐市场的发展。骨质疏鬆症是一种使骨骼脆弱易碎、容易发生骨折的疾病。其盛行率上升的主要原因是全球人口老化，而人口老化是由于随着老龄化骨骼密度自然下降，以及生活方式因素和预防保健不足所致。双磷酸盐可透过减缓骨骼分解、增强骨骼和降低骨折风险来帮助治疗骨质疏鬆症。例如，根据澳洲骨骼健康研究机构「澳洲健康骨骼」（Healthy Bones Australia）估计，2023年澳洲发生了约193,482例与骨质疏鬆症和骨质缺乏症相关的骨折，预计到2033年，这一数字将增长34%，达到237,632例。因此，骨质疏鬆症盛行率的上升正在推动双磷酸盐市场的成长。

预计研究和临床试验的增加也将推动双磷酸盐市场的成长。临床试验是指在人体受试者身上进行的研究，旨在评估新治疗方法、药物和医疗设备的安全性、有效性和潜在副作用。临床研究的增加主要是由于对创新治疗方法的需求不断增长，以满足不断变化的医疗需求并改善患者预后。使用双磷酸盐的试验透过评估其在预防和治疗骨质疏鬆症和骨转移等疾病方面的疗效和安全性，为骨骼健康疗法的发展做出了贡献。例如，根据英国製药工业协会 (ABPI) 的数据，截至 2024 年 12 月，英国由製药业主导的临床试验数量从 2022 年的 411 项增加到 2023 年的 426 项。因此，研究和临床试验的增加正在推动双磷酸盐市场的成长。

目录

第一章执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球双磷酸盐市场：吸引力评分与分析
  • 成长潜力分析、竞争评估、策略契合度评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 主要原料、资源和供应商清单
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章 全球市场趋势与策略

  • 关键技术和未来趋势
    • 生物技术、基因组学和精准医学
    • 工业4.0和智慧製造
    • 数位化、云端运算、巨量资料、网路安全
    • 永续性、气候技术和循环经济
    • 人工智慧（AI）和自主人工智慧
  • 主要趋势
    • 对骨质疏鬆症治疗的需求不断增长
    • 扩大长效注射疗法的使用
    • 非专利磷酸盐的扩张
    • 人们越来越重视骨折预防
    • 推出一套全面的骨骼健康方案

第五章 终端用户产业市场分析

  • 医院
  • 诊所
  • 居家医疗机构
  • 专业骨骼健康中心
  • 药品零售商

第六章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响，以及新冠疫情对市场的影响

第七章 全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球双磷酸盐市场：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 全球双磷酸盐市场规模、对比及成长率分析
  • 全球双磷酸盐市场表现：规模与成长，2020-2025年
  • 全球双磷酸盐市场预测：规模与成长，2025-2030年，2035年预测

第八章 全球潜在市场总量（TAM）

第九章 市场细分

  • 按类型
  • 阿崙膦酸钠、伊班膦酸钠、利塞膦酸钠、Zoledronic acid
  • 透过行政途径
  • 口服，静脉注射
  • 透过分销管道
  • 医院药局、零售药局、网路药局和其他通路
  • 透过使用
  • 骨质疏鬆症、柏哲氏病、骨转移及其他适应症
  • 最终用户
  • 医院、诊所、居家医疗机构和零售药局
  • 按类型细分：阿崙膦酸钠
  • 口服片剂，每週一次，与维生素D合併使用，非专利名阿崙膦酸钠
  • 依类型细分：伊班膦酸
  • 口服锭剂、每月一次的口服製剂、静脉注射剂、非专利伊班膦酸钠
  • 按类型细分：利塞膦酸钠
  • 速释片、缓释片、每週和每月给药方案，以及与钙剂的复方製剂
  • 依类型细分：Zoledronic acid
  • 用于治疗肿瘤和骨质疏鬆症的Zoledronic acid（非专利） ：每年静脉输註一次。

第十章 区域与国家分析

  • 全球双磷酸盐市场：区域分析、预测与趋势，2020-2025年、2025-2030年预测、2035年预测
  • 全球双磷酸盐市场：依国家、绩效及预测划分，2020-2025年、2025-2030年预测、2035年预测

第十一章 亚太市场

第十二章：中国市场

第十三章 印度市场

第十四章 日本市场

第十五章：澳洲市场

第十六章 印尼市场

第十七章 韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第二十章：西欧市场

第21章英国市场

第22章 德国市场

第23章：法国市场

第24章：义大利市场

第25章：西班牙市场

第26章 东欧市场

第27章：俄罗斯市场

第28章 北美市场

第29章：美国市场

第30章：加拿大市场

第31章 南美洲市场

第32章：巴西市场

第33章 中东市场

第34章：非洲市场

第35章 市场监理与投资环境

第36章：竞争格局与公司概况

  • 双磷酸盐市场：竞争格局与市场占有率（2024 年）
  • 双磷酸盐市场：公司估值矩阵
  • 双磷酸盐市场：公司概况
    • Merck & Co. Inc.
    • Novartis AG
    • Teva Pharmaceutical Industries Ltd.
    • Sun Pharmaceutical Industries Ltd.
    • Apotex Inc.

第37章：其他领先和创新企业

  • Aurobindo Pharma Ltd., Dr. Reddy's Laboratories Ltd., Cipla Ltd., Alkem Laboratories, Strides Pharma Science Limited, GSK plc, Viatris Inc., Sandoz, Lupin Limited, Zydus Lifesciences Ltd., Torrent Pharmaceuticals Ltd., Glenmark Pharmaceuticals Ltd., Hikma Pharmaceuticals PLC, Fresenius Kabi, Alembic Pharmaceuticals Ltd.

第38章：全球市场竞争基准分析与仪錶板

第39章 重大併购

第四十章：高潜力市场国家、细分市场与策略

  • 双磷酸盐市场展望 2030：蕴藏新机会的国家
  • 双磷酸盐市场展望 2030：充满新机会的细分市场
  • 双磷酸盐市场2030年：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第41章附录

简介目录
Product Code: PH6MBISP01_G26Q1

Bisphosphonates are a class of medications that prevent bone loss by inhibiting osteoclast activity, making them a primary treatment for osteoporosis and other conditions that weaken bones. They are commonly prescribed to reduce the risk of fractures in individuals with low bone density, Paget's disease, or bone metastases from cancer. These drugs help strengthen bones, increase bone mineral density, and lower the risk of fractures, particularly in postmenopausal women and older adults.

The main types of bisphosphonates include alendronate, ibandronate, risedronate, and zoledronic acid. Alendronate is used to treat and prevent conditions such as osteoporosis and Paget's disease. These medications can be administered orally, intravenously, subcutaneously, intraosseously, or intramuscularly and are distributed through hospital pharmacies, retail pharmacies, online pharmacies, and other channels. Key applications include osteoporosis, Paget's disease, bone metastasis, and more, serving end-users such as hospitals, clinics, homecare settings, and pharmaceutical retailers.

Tariffs have raised production and distribution costs in the bisphosphonates market by increasing prices for imported APIs and injectable drug components. Oral and intravenous bisphosphonate therapies are most impacted, particularly across Asia-Pacific and Europe where pharmaceutical imports are significant. However, tariffs are accelerating regional drug production and generic competition, supporting long-term price stability and treatment access.

The bisphosphonates market research report is one of a series of new reports from The Business Research Company that provides bisphosphonates market statistics, including bisphosphonates industry global market size, regional shares, competitors with a bisphosphonates market share, detailed bisphosphonates market segments, market trends and opportunities, and any further data you may need to thrive in the bisphosphonates industry. This bisphosphonates market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The bisphosphonates market size has grown strongly in recent years. It will grow from $5.7 billion in 2025 to $6.03 billion in 2026 at a compound annual growth rate (CAGR) of 5.8%. The growth in the historic period can be attributed to aging population growth, postmenopausal osteoporosis prevalence, physician-led bone density screening, hospital-based osteoporosis management, injectable bisphosphonate adoption.

The bisphosphonates market size is expected to see strong growth in the next few years. It will grow to $7.45 billion in 2030 at a compound annual growth rate (CAGR) of 5.4%. The growth in the forecast period can be attributed to increase in elderly population, home-based osteoporosis care, long-acting dosage preference, improved bone health awareness, generic drug penetration. Major trends in the forecast period include rising demand for osteoporosis treatments, increased use of long-acting injectable therapies, expansion of generic bisphosphonate drugs, growing focus on fracture prevention, adoption of combination bone health therapies.

The increasing prevalence of osteoporosis is expected to drive the growth of the bisphosphonates market going forward. Osteoporosis is a condition characterized by weakened bones that become fragile and more susceptible to fractures. Its prevalence is rising mainly due to the aging global population, as bone density naturally declines with age, compounded by lifestyle factors and insufficient preventive care. Bisphosphonates help treat osteoporosis by slowing bone breakdown, thereby strengthening bones and reducing fracture risk. For instance, in August 2024, according to Healthy Bones Australia, an Australia-based bone health research organization, there were an estimated 193,482 fractures related to osteoporosis and osteopenia in 2023, projected to increase by 34% to 237,632 fractures by 2033. Therefore, the increasing prevalence of osteoporosis is driving the growth of the bisphosphonates market.

The increase in research and clinical trials is also expected to propel the growth of the bisphosphonates market. Clinical trials are research studies conducted with human participants to assess the safety, efficacy, and potential side effects of new treatments, drugs, or medical devices. The rise in clinical research is primarily driven by the growing demand for innovative therapies to meet evolving healthcare needs and improve patient outcomes. Trials involving bisphosphonates advance bone health therapies by evaluating their effectiveness and safety in preventing and treating conditions such as osteoporosis and bone metastases. For instance, in December 2024, according to the Association of the British Pharmaceutical Industry (ABPI), a UK-based industry association, industry-initiated clinical trials in the UK increased from 411 in 2022 to 426 in 2023. Therefore, the increase in research and clinical trials is supporting the growth of the bisphosphonates market.

In May 2023, Abiogen Pharma S.p.A., an Italy-based pharmaceutical company, acquired EffRx Pharmaceuticals SA for an undisclosed amount. Through this acquisition, Abiogen aims to strengthen and diversify its rare disease portfolio by integrating EffRx's innovative treatments for musculoskeletal and rare conditions, while expanding its global presence and capabilities in developing and commercializing specialized therapies. EffRx Pharmaceuticals SA, based in Switzerland, manufactures and commercializes bisphosphonates for treating osteoporosis.

Major companies operating in the bisphosphonates market are Merck & Co. Inc., Novartis AG, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Apotex Inc., Aurobindo Pharma Ltd., Dr. Reddy's Laboratories Ltd., Cipla Ltd., Alkem Laboratories, Strides Pharma Science Limited, GSK plc, Viatris Inc., Sandoz, Lupin Limited, Zydus Lifesciences Ltd., Torrent Pharmaceuticals Ltd., Glenmark Pharmaceuticals Ltd., Hikma Pharmaceuticals PLC, Fresenius Kabi, Alembic Pharmaceuticals Ltd.

North America was the largest region in the bisphosphonates market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bisphosphonates market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the bisphosphonates market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The bisphosphonates market consists of sales of oral tablets, bisphosphonate capsules, bisphosphonate injections, oral solutions, and intravenous (IV) infusions. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Bisphosphonates Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses bisphosphonates market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for bisphosphonates ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The bisphosphonates market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Type: Alendronate; Ibandronate; Risedronate; Zoledronic Acid
  • 2) By Route Of Administration: Oral; Intravenous
  • 3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies; Other Distribution Channels
  • 4) By Application: Osteoporosis; Paget's Disease; Bone Metastasis; Other Application
  • 5) By End-User: Hospitals; Clinics; Homecare Settings; Pharmaceutical Retail
  • Subsegments:
  • 1) By Alendronate: Oral Tablets; Once-Weekly Formulation; Combination With Vitamin D; Generic Alendronate
  • 2) By Ibandronate: Oral Tablets; Monthly Oral Formulation; Intravenous Injection; Generic Ibandronate
  • 3) By Risedronate: Immediate-Release Tablets; Delayed-Release Tablets; Weekly And Monthly Dosing; Combination With Calcium
  • 4) By Zoledronic Acid: Intravenous Infusion; Annual Dosing; Oncology Use; Osteoporosis Use; Generic Zoledronic Acid
  • Companies Mentioned: Merck & Co. Inc.; Novartis AG; Teva Pharmaceutical Industries Ltd.; Sun Pharmaceutical Industries Ltd.; Apotex Inc.; Aurobindo Pharma Ltd.; Dr. Reddy's Laboratories Ltd.; Cipla Ltd.; Alkem Laboratories; Strides Pharma Science Limited; GSK plc; Viatris Inc.; Sandoz; Lupin Limited; Zydus Lifesciences Ltd.; Torrent Pharmaceuticals Ltd.; Glenmark Pharmaceuticals Ltd.; Hikma Pharmaceuticals PLC; Fresenius Kabi; Alembic Pharmaceuticals Ltd.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Bisphosphonates Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Bisphosphonates Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Bisphosphonates Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Bisphosphonates Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Industry 4.0 & Intelligent Manufacturing
    • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.4 Sustainability, Climate Tech & Circular Economy
    • 4.1.5 Artificial Intelligence & Autonomous Intelligence
  • 4.2. Major Trends
    • 4.2.1 Rising Demand For Osteoporosis Treatments
    • 4.2.2 Increased Use Of Long-Acting Injectable Therapies
    • 4.2.3 Expansion Of Generic Bisphosphonate Drugs
    • 4.2.4 Growing Focus On Fracture Prevention
    • 4.2.5 Adoption Of Combination Bone Health Therapies

5. Bisphosphonates Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Clinics
  • 5.3 Homecare Settings
  • 5.4 Specialty Bone Health Centers
  • 5.5 Pharmaceutical Retailers

6. Bisphosphonates Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Bisphosphonates Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Bisphosphonates PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Bisphosphonates Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Bisphosphonates Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Bisphosphonates Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Bisphosphonates Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Bisphosphonates Market Segmentation

  • 9.1. Global Bisphosphonates Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Alendronate, Ibandronate, Risedronate, Zoledronic Acid
  • 9.2. Global Bisphosphonates Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Oral, Intravenous
  • 9.3. Global Bisphosphonates Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels
  • 9.4. Global Bisphosphonates Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Osteoporosis, Paget's Disease, Bone Metastasis, Other Application
  • 9.5. Global Bisphosphonates Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals, Clinics, Homecare Settings, Pharmaceutical Retail
  • 9.6. Global Bisphosphonates Market, Sub-Segmentation Of Alendronate, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Oral Tablets, Once-Weekly Formulation, Combination With Vitamin D, Generic Alendronate
  • 9.7. Global Bisphosphonates Market, Sub-Segmentation Of Ibandronate, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Oral Tablets, Monthly Oral Formulation, Intravenous Injection, Generic Ibandronate
  • 9.8. Global Bisphosphonates Market, Sub-Segmentation Of Risedronate, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Immediate-Release Tablets, Delayed-Release Tablets, Weekly And Monthly Dosing, Combination With Calcium
  • 9.9. Global Bisphosphonates Market, Sub-Segmentation Of Zoledronic Acid, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Intravenous Infusion, Annual Dosing, Oncology Use, Osteoporosis Use, Generic Zoledronic Acid

10. Bisphosphonates Market Regional And Country Analysis

  • 10.1. Global Bisphosphonates Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Bisphosphonates Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Bisphosphonates Market

  • 11.1. Asia-Pacific Bisphosphonates Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Bisphosphonates Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Bisphosphonates Market

  • 12.1. China Bisphosphonates Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Bisphosphonates Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Bisphosphonates Market

  • 13.1. India Bisphosphonates Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Bisphosphonates Market

  • 14.1. Japan Bisphosphonates Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Bisphosphonates Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Bisphosphonates Market

  • 15.1. Australia Bisphosphonates Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Bisphosphonates Market

  • 16.1. Indonesia Bisphosphonates Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Bisphosphonates Market

  • 17.1. South Korea Bisphosphonates Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Bisphosphonates Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Bisphosphonates Market

  • 18.1. Taiwan Bisphosphonates Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Bisphosphonates Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Bisphosphonates Market

  • 19.1. South East Asia Bisphosphonates Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Bisphosphonates Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Bisphosphonates Market

  • 20.1. Western Europe Bisphosphonates Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Bisphosphonates Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Bisphosphonates Market

  • 21.1. UK Bisphosphonates Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Bisphosphonates Market

  • 22.1. Germany Bisphosphonates Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Bisphosphonates Market

  • 23.1. France Bisphosphonates Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Bisphosphonates Market

  • 24.1. Italy Bisphosphonates Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Bisphosphonates Market

  • 25.1. Spain Bisphosphonates Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Bisphosphonates Market

  • 26.1. Eastern Europe Bisphosphonates Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Bisphosphonates Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Bisphosphonates Market

  • 27.1. Russia Bisphosphonates Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Bisphosphonates Market

  • 28.1. North America Bisphosphonates Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Bisphosphonates Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Bisphosphonates Market

  • 29.1. USA Bisphosphonates Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Bisphosphonates Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Bisphosphonates Market

  • 30.1. Canada Bisphosphonates Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Bisphosphonates Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Bisphosphonates Market

  • 31.1. South America Bisphosphonates Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Bisphosphonates Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Bisphosphonates Market

  • 32.1. Brazil Bisphosphonates Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Bisphosphonates Market

  • 33.1. Middle East Bisphosphonates Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Bisphosphonates Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Bisphosphonates Market

  • 34.1. Africa Bisphosphonates Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Bisphosphonates Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Bisphosphonates Market Regulatory and Investment Landscape

36. Bisphosphonates Market Competitive Landscape And Company Profiles

  • 36.1. Bisphosphonates Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Bisphosphonates Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Bisphosphonates Market Company Profiles
    • 36.3.1. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Teva Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Sun Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Apotex Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Bisphosphonates Market Other Major And Innovative Companies

  • Aurobindo Pharma Ltd., Dr. Reddy's Laboratories Ltd., Cipla Ltd., Alkem Laboratories, Strides Pharma Science Limited, GSK plc, Viatris Inc., Sandoz, Lupin Limited, Zydus Lifesciences Ltd., Torrent Pharmaceuticals Ltd., Glenmark Pharmaceuticals Ltd., Hikma Pharmaceuticals PLC, Fresenius Kabi, Alembic Pharmaceuticals Ltd.

38. Global Bisphosphonates Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Bisphosphonates Market

40. Bisphosphonates Market High Potential Countries, Segments and Strategies

  • 40.1 Bisphosphonates Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Bisphosphonates Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Bisphosphonates Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer